Aark Pharmaceuticals Private Limited
Breakthrough Multiple Myeloma Medicines Accessible in India
List of following breakthrough Multiple Myeloma medicines accessible for patients in India which has been recently launched in India. Below mentioned medicine is available in India to patients, doctors, chain pharmacy, chain hospitals, B2C pharmacies, and others. If you need an assistance or have questions for above drug please contact Aark at Email: sales@aarkpharma.co.in or give us a call at M:+91 9999156233 / (+91) 99534-66646.
Multiple Myeloma Treatment Medicines
Multiple myeloma treatments involve various drug classes like Proteasome Inhibitors (Bortezomib, Carfilzomib, Ixazomib), Immunomodulatory Drugs (IMiDs) (Lenalidomide, Pomalidomide, Thalidomide), and Monoclonal Antibodies (Daratumumab, Elotuzumab).
Often used in combinations with Corticosteroids (like Dexamethasone) and sometimes Chemotherapy, newer options include CAR T-cell therapies and Bispecific Antibodies, all aiming to kill plasma cells, stop growth, and boost the immune system, with common combinations like Daratumumab-VRd (Dara-Bortezomib-Lenalidomide-Dexamethasone) offering deep remissions.
Contact Distributors/Suppliers.
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
List of FDA-Approved Multiple Myeloma Medicine Breakthroughs available in India
Reach out to authorized suppliers for genuine product access across India.
Contact Us – For Breakthrough Drugs Inquiries
For latest breakthrough Kidney Medications – Now in India for Patients, Doctors, clinics, hospitals, Pharmacy, B2B Platform. We would love to speak with you. Feel free to reach out using the below details.
Mumbai Office :
9999156233
(Mrs. Himanshi)
Lucknow Office :
7065025552
(Mr. Krishna Kant)
Varanasi Office :
8010447290
(Mr. Dharmendra)
Chandigarh Office :
9876604101
(Mr Bikram)
Kolkata Office :
9810264781
(Mr Surjit)
Patna Office :
9310817125
(Mr. Chitranjan)
Jodhpur Office :
9899245300
(Mr Raju).
Contact
For any inquiries
Buy 100% authentic medicines from Aark Pharmaceuticals. Aark Pharmaceuticals is a Government approved pharmaceutical CFA, Distributors & Retailers of leading medicine manufacturers in India. * Get the best price & exclusive discounts on all Multiple Myeloma – Blood Cancer Medicines Treatment Medicines today! Call/WhatsApp Aark Pharmaceuticals at 9999156233 (Ms.Himansh), 9871948310 (Mr.Dheeraj) for instant availability.
Why India Is Emerging as a Hub for Multiple Myeloma Treatment
India is rapidly becoming a preferred global destination for Multiple Myeloma (MM) treatment, offering advanced therapies, internationally trained specialists, and cost-effective care. Patients from across the world are turning to India for cutting-edge options in managing this complex blood cancer.
1. Expert Hematologists & Oncologists
India has a strong network of hematologists, oncologists, and bone marrow transplant specialists with deep expertise in treating Multiple Myeloma. Many have trained at renowned global cancer institutes and bring extensive experience in handling advanced cases.
2. Advanced Diagnostic & Therapeutic Options
Top Indian hospitals offer precise diagnostics such as bone marrow biopsy, flow cytometry, FISH, cytogenetics, and PET-CT scans. Treatment options include:
Targeted therapies (proteasome inhibitors, immunomodulators)
Immunotherapy & monoclonal antibodies
Chemotherapy & radiation therapy
Autologous & allogeneic stem cell / bone marrow transplant
3. High Success Rates in Stem Cell Transplant
Stem cell transplant is a cornerstone of Multiple Myeloma treatment. Leading Indian cancer centers report transplant success rates on par with global standards, thanks to advanced facilities and skilled teams.
4. Affordable Treatment Compared to the West
Multiple Myeloma treatment in India—including novel drug therapies and stem cell transplants—is 60–70% more cost-effective compared to the US and Europe, making it accessible to international patients.
5. World-Class Cancer Hospitals
India’s leading cancer hospitals are NABH and JCI accredited, ensuring global treatment standards, advanced infection control, and comprehensive patient safety protocols.
6. Comprehensive Patient Support & Follow-up
Hospitals in India provide integrated care, including nutritional support, pain management, rehabilitation, and long-term monitoring—crucial for chronic conditions like Multiple Myeloma.
7. Medical Tourism & Global Access
With streamlined medical visas, English-speaking staff, and international patient care departments, India has become a reliable hub for medical tourism in cancer care, especially for Multiple Myeloma.
We Have Supplied Medicines To Following Cities In India –
Disclaimer: We hereby declare that Aark Pharmaceuticals exclusively exports biosimilars or generic medicines manufactured in India. We do not export products manufactured by multinational companies. Our commitment lies in offering cost-effective healthcare solutions through generic medications, ensuring accessibility and affordability for all our customers. For any inquiries or assistance regarding our product range, please feel free to contact us.